Results 161 to 170 of about 9,895,330 (357)
Molecular Oncology, EarlyView.Alectinib resistance in ALK+ NSCLC depends on treatment sequence and EML4‐ALK variants. Variant 1 exhibited off‐target resistance after first‐line treatment, while variant 3 and later lines favored on‐target mutations. Early resistance involved off‐target alterations, like MET and NF2, while on‐target mutations emerged with prolonged therapy.
Jie Hu +11 more
wiley +1 more source
THE THERAPEUTIC ACTION OF TONICA WATER. WITH THE HISTORY OF TWENTY-SIX CASES WHERE IT HAS BEEN USED.Read in the Section of Practice of Medicine and Physiology, at the Forty-second Annual Meeting of the American Medical Association, held at Washington, D. C., May, 1891. [PDF]
, 1891 J. W. SMALL
openalex +1 more source
Medical history predicts phenome-wide disease onset and enables the rapid response to emerging health threats. [PDF]
Nat CommunSteinfeldt J +12 more
europepmc +2 more sources
Comparison of medical history documentation efficiency and quality based on GPT-4o: a study on the comparison between residents and artificial intelligence. [PDF]
Front Med (Lausanne)Lu X +8 more
europepmc +1 more source
Molecular Oncology, EarlyView.This study used longitudinal transcriptomics and gene‐pattern classification to uncover patient‐specific mechanisms of chemotherapy resistance in breast cancer. Findings reveal preexisting drug‐tolerant states in primary tumors and diverse gene rewiring patterns across patients, converging on a few dysregulated functional modules. Despite receiving the
Maya Dadiani +14 more
wiley +1 more source